VISTAGEN THERAPEUTICS, INC. Share Price
VISTAGEN THERAPEUTICS, INC. (VTGN) had Share Price of $1.27 per share as of 2018-09-30, per its 10-Q filed 2018-10-29.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2018-10-29
- 2018-09-30: Share Price $1.27.
- 2016-03-31: Share Price $8.75.
- 2014-09-30: Share Price $15.74.
| Period end | Share Price |
|---|---|
| 2018-09-30 | $1.27 10-Q · filed 2018-10-29 |
| 2016-03-31 | $8.75 10-K · filed 2016-06-24 |
| 2014-09-30 | $15.74 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |